Annual Cash & Cash Equivalents
$897.70 K
-$8.05 M-89.97%
01 December 2023
Summary:
NLS Pharmaceutics AG annual cash & cash equivalents is currently $897.70 thousand, with the most recent change of -$8.05 million (-89.97%) on 01 December 2023. During the last 3 years, it has risen by +$804.00 thousand (+858.06%). NLSP annual cash & cash equivalents is now -89.97% below its all-time high of $8.95 million, reached on 31 December 2022.NLSP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$552.80 K
-$344.90 K-38.42%
01 June 2024
Summary:
NLS Pharmaceutics AG quarterly cash and cash equivalents is currently $552.80 thousand, with the most recent change of -$344.90 thousand (-38.42%) on 01 June 2024. Over the past year, it has dropped by -$1.10 million (-66.53%). NLSP quarterly cash and cash equivalents is now -93.82% below its all-time high of $8.95 million, reached on 31 December 2022.NLSP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.0% | -66.5% |
| 3 y3 years | +858.1% | -92.2% |
| 5 y5 years | +10000.0% | -54.9% |
NLSP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -90.0% | +858.1% | -93.8% | at low |
| 5 y | 5 years | -90.0% | >+9999.0% | -93.8% | +490.0% |
| alltime | all time | -90.0% | >+9999.0% | -93.8% | +8150.8% |
NLS Pharmaceutics AG Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $552.80 K(-38.4%) |
| Dec 2023 | $897.70 K(-90.0%) | $897.70 K(-45.6%) |
| June 2023 | - | $1.65 M(-81.5%) |
| Dec 2022 | $8.95 M(+64.8%) | $8.95 M(+560.8%) |
| June 2022 | - | $1.35 M(-75.1%) |
| Dec 2021 | $5.43 M | $5.43 M(-23.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $7.09 M(+7468.9%) |
| Dec 2020 | $93.70 K(-57.5%) | $93.70 K(-35.6%) |
| June 2020 | - | $145.40 K(-34.0%) |
| Dec 2019 | $220.30 K(+3188.1%) | $220.30 K(-82.0%) |
| June 2019 | - | $1.22 M(>+9900.0%) |
| Dec 2018 | $6700.00(-99.7%) | $6700.00 |
| Dec 2017 | $2.18 M | - |
FAQ
- What is NLS Pharmaceutics AG annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual cash & cash equivalents year-on-year change?
- What is NLS Pharmaceutics AG quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG quarterly cash and cash equivalents year-on-year change?
What is NLS Pharmaceutics AG annual cash & cash equivalents?
The current annual cash & cash equivalents of NLSP is $897.70 K
What is the all time high annual cash & cash equivalents for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual cash & cash equivalents is $8.95 M
What is NLS Pharmaceutics AG annual cash & cash equivalents year-on-year change?
Over the past year, NLSP annual cash & cash equivalents has changed by -$8.05 M (-89.97%)
What is NLS Pharmaceutics AG quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NLSP is $552.80 K
What is the all time high quarterly cash and cash equivalents for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high quarterly cash and cash equivalents is $8.95 M
What is NLS Pharmaceutics AG quarterly cash and cash equivalents year-on-year change?
Over the past year, NLSP quarterly cash and cash equivalents has changed by -$1.10 M (-66.53%)